Optimal Construction and Delivery of Dual-Functioning Lentiviral Vectors for Type I Collagen-Suppressed Chondrogenesis in Synovium-Derived Mesenchymal Stem Cells
- 184 Downloads
This study aims to deliver both transforming growth factor β3 (TGF-β3) and shRNA targeting type I collagen (Col I) by optimal construction and application of various dual-functioning lentiviral vectors to induce Col I-suppressed chondrogenesis in synovium-derived mesenchymal stem cells (SMSCs).
We constructed four lentiviral vectors (LV-1, LV-2, LV-3 and LV-4) with various arrangements of the two expression cassettes in different positions and orientations. Col I inhibition efficiency and chondrogenic markers were assessed with qPCR, ELISA and staining techniques. Among the four vectors, LV-1 has two distant and reversely oriented cassettes, LV-2 has two distant and same-oriented cassettes, LV-3 has two proximal and reversely oriented cassettes, and LV-4 has two proximal and same-oriented cassettes. Col I and chondrogenic markers, including type II collagen (Col II), aggrecan and glycosaminoglycan (GAG), were examined in SMSCs cultured in 3-D alginate hydrogel.
All of the four vectors showed distinct effects in Col I level as well as diverse inductive efficiencies in upregulation of the cartilaginous markers. Based on real-time PCR results, LV-1 was optimal towards Col I-suppressed chondrogenesis.
LV-1 vector is competent to promote Col I-suppressed chondrogenesis in SMSCs.
KEY WORDSdual-functioning lentiviral vector synovial mesenchymal stem cells (SMSCs) TGF-β3 type I collagen chondrogenesis
- Col I
type I collagen
- Col II
type II collagen
recombinant lentiviral vector that expresses both shRNA targeting type I collagen and TGF- β3
recombinant lentiviral vector that specifically expresses TGF-β3
short hairpin RNA
synovium-derived mesenchymal stem cell
transforming growth factor-β3
This research was financially supported by AcRF Tier 1 Grant RG64/08, Ministry of Education (MoE), and NMRC/EDG/1001/2010, Singapore.
- 2.Buckwalter JA. Articular cartilage injuries. Clin Orthop Relat Res. 2002;21-37.Google Scholar
- 7.RR Varshney, R Zhou, J Hao, SS Yeo, WH Chooi, J Fan, DA Wang: Chondrogenesis of synovium-derived mesenchymal stem cells in gene-transferred co-culture system. Biomaterials. 31: 6876-91.Google Scholar
- 10.Zhang F, Yao Y, Hao J, Zhou R, Liu C, Gong Y, Wang DA. A dual-functioning adenoviral vector encoding both transforming growth factor-beta3 and shRNA silencing type I collagen: construction and controlled release for chondrogenesis. J Control Release. 142:70–7.Google Scholar
- 15.Yao Y, Zhang F, Zhou R, Su K, Fan J, Wang DA. Effects of combinational adenoviral vector-mediated TGF beta 3 transgene and shRNA silencing type I collagen on articular chondrogenesis of synovium-derived mesenchymal stem cells. Biotechnol Bioeng. 106:818–28.Google Scholar